Index of medicine substances

Pinene + camphene + cineole + fenchone + borneol + anethole  •  Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs for urinary frequency and incontinence (G04BDN1)

Pioglitazone  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Thiazolidinediones (A10BG03)

Pioglitazone + glimepiride  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD06)

Pioglitazone + metformin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD05)

Pipecuronium bromide  •  Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other quaternary ammonium compounds (M03AC06)

Piperacillin + tazobactam  •  Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors (J01CR05)

Piracetam  •  Nervous system | Psychostimulants, agents used for adhd and nootropics | Other psychostimulants and nootropics (N06BX03)

Pirfenidone  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants (L04AX05)

Piribedil  •  Nervous system | Dopaminergic agents | Dopamine agonists (N04BC08)

Pirtobrutinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Bruton's tyrosine kinase (BTK) inhibitors (L01EL05)

Pitavastatin  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors (C10AA08)

Pitavastatin + ezetimibe  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Combinations of various lipid modifying agents (C10BA13)

Pitolisant  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX11)

Plantain extract  •  Respiratory system | Expectorants, excl. combinations with cough suppressants (R05CA10)

Plants  •  Alimentary tract and metabolism | Stomatological preparations | Stomatological preparations | Other agents for local oral treatment (A01AD11)

Plants + combinations  •  Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Other drugs used in benign prostatic hypertrophy (G04CXN4)

Plerixafor  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants (L03AX16)

Pneumococcal polysaccharide conjugate vaccine 21-valent  •  Antiinfectives for systemic use | Bacterial vaccines | Pneumococcal vaccines (J07AL02)

Podophyllotoxin  •  Dermatologicals | Chemotherapeutics for topical use | Antivirals (D06BB04)

Polatuzumab vedotin  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates (L01FX14)

Polygeline  •  Blood and blood forming organs | Blood and related products | Blood substitutes and plasma protein fractions (B05AA06)

Polyhexanide  •  Sensory organs | Antiinfectives | Other antiinfectives (S01AX24)

Polymaltose iron (III) hydroxide complex  •  Blood and blood forming organs | Iron preparations | Iron trivalent, oral preparations (B03AB05)

Polymyxin  •  Alimentary tract and metabolism | Stomatological preparations | Stomatological preparations | Corticosteroids for local oral treatment (A01ACN1)

Polysaccharide conjugate pneumococcal vaccine  •  Antiinfectives for systemic use | Bacterial vaccines | Pneumococcal vaccines (J07AL52)

Polysaccharide meningococcal vaccine  •  Antiinfectives for systemic use | Bacterial vaccines | Meningococcal vaccines (J07AH03)

Polysaccharide pneumococcal vaccine  •  Antiinfectives for systemic use | Bacterial vaccines | Pneumococcal vaccines (J07AL01)

Polysulfated mucopolysaccharide + salicylic acid  •  Musculo-skeletal system | Topical products for joint and muscular pain | Topical products for joint and muscular pain | Preparations with salicylic acid derivatives (M02ACN1)

Pomalidomide  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants (L04AX06)

Ponatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors (L01EA05)